Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database
BÉGAUD, Bernard
Pharmacoepidemiologie et évaluation de l'impact des produits de santé sur les populations
< Reduce
Pharmacoepidemiologie et évaluation de l'impact des produits de santé sur les populations
Language
en
Article de revue
This item was published in
Drug Safety. 2017-11, vol. 40, n° 11, p. 1099-1107
Springer Verlag
English Abstract
The objective of this study was to analyse the changes in the reporting of adverse events (AEs) for therapeutic alternatives after the withdrawal of three medicines (dextropropoxyphene, pioglitazone and tetrazepam) from ...Read more >
The objective of this study was to analyse the changes in the reporting of adverse events (AEs) for therapeutic alternatives after the withdrawal of three medicines (dextropropoxyphene, pioglitazone and tetrazepam) from the market for safety reasons.Read less <
English Keywords
medicine
therapeutic alternatives
politics
ANR Project
Initiative d'excellence de l'Université de Bordeaux - ANR-10-IDEX-0003
Origin
Hal imported